APA

Harsing L. G., Timar J., Szabo G., Udvari S., Nagy K. M., Marko B., Zsilla G., Czompa A., Tapolcsanyi P., Kocsis A. & Matyus P. (20160509). Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms. : Current pharmaceutical design.

Chicago

Harsing Laszlo G, Timar Julia, Szabo Geza, Udvari Szabolcs, Nagy Katalin M, Marko Bernadett, Zsilla Gabriella, Czompa Andrea, Tapolcsanyi Pal, Kocsis Akos and Matyus Peter. 20160509. Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms. : Current pharmaceutical design.

Harvard

Harsing L. G., Timar J., Szabo G., Udvari S., Nagy K. M., Marko B., Zsilla G., Czompa A., Tapolcsanyi P., Kocsis A. and Matyus P. (20160509). Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms. : Current pharmaceutical design.

MLA

Harsing Laszlo G, Timar Julia, Szabo Geza, Udvari Szabolcs, Nagy Katalin M, Marko Bernadett, Zsilla Gabriella, Czompa Andrea, Tapolcsanyi Pal, Kocsis Akos and Matyus Peter. Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms. : Current pharmaceutical design. 20160509.